{"id":27144,"date":"2021-06-11T11:01:15","date_gmt":"2021-06-11T09:01:15","guid":{"rendered":"https:\/\/www.satt.fr\/lysogene-signe-un-accord-exclusif-de-licence-mondiale-avec-la-satt-conectus\/"},"modified":"2021-06-11T11:01:15","modified_gmt":"2021-06-11T09:01:15","slug":"lysogene-signe-un-accord-exclusif-de-licence-mondiale-avec-la-satt-conectus","status":"publish","type":"post","link":"https:\/\/www.satt.fr\/en\/lysogene-signe-un-accord-exclusif-de-licence-mondiale-avec-la-satt-conectus\/","title":{"rendered":"Lysogene signe un accord exclusif de licence mondiale avec la SATT Conectus"},"content":{"rendered":"<p><strong><span style=\"color: #c90f4c;\">Lysogene, soci\u00e9t\u00e9 biopharmaceutique de phase 3 s\u2019appuyant sur une plateforme technologique de th\u00e9rapie g\u00e9nique ciblant les maladies du syst\u00e8me nerveux central (SNC),\u00a0 signe un accord exclusif de licence mondiale avec la SATT Conectus pour le d\u00e9veloppement et la commercialisation d\u2019un candidat m\u00e9dicament de th\u00e9rapie g\u00e9nique dans le traitement du syndrome de l\u2019X Fragile.<\/span><\/strong><\/p>\n<p>Le syndrome de l\u2019X Fragile touche approximativement 1 naissance sur 4 000 \u00e0 5 000 gar\u00e7ons et 1 naissance sur 8 000 filles, soit environ 110 000 patients en Europe et environ 70 000 patients aux Etats-Unis. Il est aujourd\u2019hui la <strong>premi\u00e8re cause h\u00e9r\u00e9ditaire de d\u00e9ficience intellectuelle<\/strong> ainsi que la premi\u00e8re cause connue de troubles du spectre autistique, et il n\u2019a pas encore de traitement curatif.<\/p>\n<p><strong>Lysogene sera responsable du d\u00e9veloppement, de la fabrication, des activit\u00e9s r\u00e9glementaires et de la commercialisation du candidat m\u00e9dicament au niveau mondial<\/strong>. Ce candidat m\u00e9dicament de th\u00e9rapie g\u00e9nique vise \u00e0 compenser la r\u00e9duction de DGKk, une cible th\u00e9rapeutique innovante dont la synth\u00e8se est sous le contr\u00f4le de la prot\u00e9ine FMRP (Fragile-X Mental retardation protein), la prot\u00e9ine manquante responsable du syndrome de l\u2019X Fragile.<\/p>\n<p>Lysogene collabore depuis 2018 avec le <strong>Dr Herv\u00e9 Moine de l&#8217;Institut de G\u00e9n\u00e9tique et de Biologie Mol\u00e9culaire et Cellulaire (IGBMC) de Strasbourg et la SATT Conectus, Soci\u00e9t\u00e9 d&#8217;Acc\u00e9l\u00e9ration et de Transfert de Technologies du territoire Alsace.<\/strong><\/p>\n<p><span style=\"color: #c90f4c;\"><strong>Depuis 2012, Conectus a concr\u00e9tis\u00e9 120 transferts de technologies.<\/strong><\/span><\/p>\n<p>&nbsp;<\/p>\n<p><span style=\"color: #c90f4c;\"><a style=\"color: #c90f4c;\" href=\"https:\/\/www.conectus.fr\/lysogene-signe-un-accord-exclusif-de-licence-mondiale-avec-la-satt-conectus\"><strong>Lire le communiqu\u00e9 de presse int\u00e9gral<\/strong><\/a><\/span><\/p>\n<p><span style=\"color: #c90f4c;\"><a style=\"color: #c90f4c;\" href=\"https:\/\/www.lysogene.com\/?lang=fr\"><strong>D\u00e9couvrir Lysog\u00e8ne<\/strong><\/a><\/span><\/p>\n<p><span style=\"color: #c90f4c;\"><a style=\"color: #c90f4c;\" href=\"https:\/\/www.conectus.fr\/\"><strong>D\u00e9couvrir Conectus<\/strong><\/a>\u00a0<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Lysogene, soci\u00e9t\u00e9 biopharmaceutique de phase 3 s\u2019appuyant sur une plateforme technologique de th\u00e9rapie g\u00e9nique ciblant les maladies du syst\u00e8me nerveux central (SNC),\u00a0 signe un accord exclusif de licence mondiale avec la SATT Conectus pour le d\u00e9veloppement et la commercialisation d\u2019un candidat m\u00e9dicament de th\u00e9rapie g\u00e9nique dans le traitement du syndrome de l\u2019X Fragile. Le syndrome [&hellip;]<\/p>\n","protected":false},"author":7,"featured_media":27145,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[567,568],"tags":[],"class_list":["post-27144","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en","category-successstories-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Lysogene signe un accord exclusif de licence mondiale avec la SATT Conectus - R\u00e9seau SATT<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.satt.fr\/en\/lysogene-signe-un-accord-exclusif-de-licence-mondiale-avec-la-satt-conectus\/\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"France MANDRY\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.satt.fr\/en\/lysogene-signe-un-accord-exclusif-de-licence-mondiale-avec-la-satt-conectus\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.satt.fr\/en\/lysogene-signe-un-accord-exclusif-de-licence-mondiale-avec-la-satt-conectus\/\"},\"author\":{\"name\":\"France MANDRY\",\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/3c07a164c17f01f656480221ba81ab4e\"},\"headline\":\"Lysogene signe un accord exclusif de licence mondiale avec la SATT Conectus\",\"datePublished\":\"2021-06-11T09:01:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.satt.fr\/en\/lysogene-signe-un-accord-exclusif-de-licence-mondiale-avec-la-satt-conectus\/\"},\"wordCount\":278,\"image\":{\"@id\":\"https:\/\/www.satt.fr\/en\/lysogene-signe-un-accord-exclusif-de-licence-mondiale-avec-la-satt-conectus\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2021\/06\/Capture-e1623402013143.png\",\"articleSection\":[\"News\",\"Success Stories\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.satt.fr\/en\/lysogene-signe-un-accord-exclusif-de-licence-mondiale-avec-la-satt-conectus\/\",\"url\":\"https:\/\/www.satt.fr\/en\/lysogene-signe-un-accord-exclusif-de-licence-mondiale-avec-la-satt-conectus\/\",\"name\":\"Lysogene signe un accord exclusif de licence mondiale avec la SATT Conectus - R\u00e9seau SATT\",\"isPartOf\":{\"@id\":\"https:\/\/www.satt.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.satt.fr\/en\/lysogene-signe-un-accord-exclusif-de-licence-mondiale-avec-la-satt-conectus\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.satt.fr\/en\/lysogene-signe-un-accord-exclusif-de-licence-mondiale-avec-la-satt-conectus\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2021\/06\/Capture-e1623402013143.png\",\"datePublished\":\"2021-06-11T09:01:15+00:00\",\"author\":{\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/3c07a164c17f01f656480221ba81ab4e\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.satt.fr\/en\/lysogene-signe-un-accord-exclusif-de-licence-mondiale-avec-la-satt-conectus\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.satt.fr\/en\/lysogene-signe-un-accord-exclusif-de-licence-mondiale-avec-la-satt-conectus\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.satt.fr\/en\/lysogene-signe-un-accord-exclusif-de-licence-mondiale-avec-la-satt-conectus\/#primaryimage\",\"url\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2021\/06\/Capture-e1623402013143.png\",\"contentUrl\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2021\/06\/Capture-e1623402013143.png\",\"width\":600,\"height\":303},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.satt.fr\/en\/lysogene-signe-un-accord-exclusif-de-licence-mondiale-avec-la-satt-conectus\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.satt.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lysogene signe un accord exclusif de licence mondiale avec la SATT Conectus\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.satt.fr\/en\/#website\",\"url\":\"https:\/\/www.satt.fr\/en\/\",\"name\":\"R\u00e9seau SATT\",\"description\":\"Les Soci\u00e9t\u00e9s d&#039;Acc\u00e9l\u00e9ration du Transfert de Technologies\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.satt.fr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/3c07a164c17f01f656480221ba81ab4e\",\"name\":\"France MANDRY\",\"url\":\"https:\/\/www.satt.fr\/en\/author\/france\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lysogene signe un accord exclusif de licence mondiale avec la SATT Conectus - R\u00e9seau SATT","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.satt.fr\/en\/lysogene-signe-un-accord-exclusif-de-licence-mondiale-avec-la-satt-conectus\/","twitter_misc":{"Written by":"France MANDRY","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.satt.fr\/en\/lysogene-signe-un-accord-exclusif-de-licence-mondiale-avec-la-satt-conectus\/#article","isPartOf":{"@id":"https:\/\/www.satt.fr\/en\/lysogene-signe-un-accord-exclusif-de-licence-mondiale-avec-la-satt-conectus\/"},"author":{"name":"France MANDRY","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/3c07a164c17f01f656480221ba81ab4e"},"headline":"Lysogene signe un accord exclusif de licence mondiale avec la SATT Conectus","datePublished":"2021-06-11T09:01:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.satt.fr\/en\/lysogene-signe-un-accord-exclusif-de-licence-mondiale-avec-la-satt-conectus\/"},"wordCount":278,"image":{"@id":"https:\/\/www.satt.fr\/en\/lysogene-signe-un-accord-exclusif-de-licence-mondiale-avec-la-satt-conectus\/#primaryimage"},"thumbnailUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2021\/06\/Capture-e1623402013143.png","articleSection":["News","Success Stories"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.satt.fr\/en\/lysogene-signe-un-accord-exclusif-de-licence-mondiale-avec-la-satt-conectus\/","url":"https:\/\/www.satt.fr\/en\/lysogene-signe-un-accord-exclusif-de-licence-mondiale-avec-la-satt-conectus\/","name":"Lysogene signe un accord exclusif de licence mondiale avec la SATT Conectus - R\u00e9seau SATT","isPartOf":{"@id":"https:\/\/www.satt.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.satt.fr\/en\/lysogene-signe-un-accord-exclusif-de-licence-mondiale-avec-la-satt-conectus\/#primaryimage"},"image":{"@id":"https:\/\/www.satt.fr\/en\/lysogene-signe-un-accord-exclusif-de-licence-mondiale-avec-la-satt-conectus\/#primaryimage"},"thumbnailUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2021\/06\/Capture-e1623402013143.png","datePublished":"2021-06-11T09:01:15+00:00","author":{"@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/3c07a164c17f01f656480221ba81ab4e"},"breadcrumb":{"@id":"https:\/\/www.satt.fr\/en\/lysogene-signe-un-accord-exclusif-de-licence-mondiale-avec-la-satt-conectus\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.satt.fr\/en\/lysogene-signe-un-accord-exclusif-de-licence-mondiale-avec-la-satt-conectus\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.satt.fr\/en\/lysogene-signe-un-accord-exclusif-de-licence-mondiale-avec-la-satt-conectus\/#primaryimage","url":"https:\/\/www.satt.fr\/wp-content\/uploads\/2021\/06\/Capture-e1623402013143.png","contentUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2021\/06\/Capture-e1623402013143.png","width":600,"height":303},{"@type":"BreadcrumbList","@id":"https:\/\/www.satt.fr\/en\/lysogene-signe-un-accord-exclusif-de-licence-mondiale-avec-la-satt-conectus\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.satt.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Lysogene signe un accord exclusif de licence mondiale avec la SATT Conectus"}]},{"@type":"WebSite","@id":"https:\/\/www.satt.fr\/en\/#website","url":"https:\/\/www.satt.fr\/en\/","name":"R\u00e9seau SATT","description":"Les Soci\u00e9t\u00e9s d&#039;Acc\u00e9l\u00e9ration du Transfert de Technologies","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.satt.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/3c07a164c17f01f656480221ba81ab4e","name":"France MANDRY","url":"https:\/\/www.satt.fr\/en\/author\/france\/"}]}},"_links":{"self":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/27144","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/comments?post=27144"}],"version-history":[{"count":0,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/27144\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/media\/27145"}],"wp:attachment":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/media?parent=27144"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/categories?post=27144"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/tags?post=27144"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}